SuperworthBone Biologics shares outstanding BBLG
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 1.8M
- On a year earlier
- +222.1%
- more shares
Bone Biologics had 1.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 222.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.8M | +335% |
| FY2024 | 412.3K | +441% |
| FY2023 | 76.1K | +651% |
| FY2022 | 10.1K | +56% |
| FY2021 | 6.5K | +222% |
| FY2020 | 2K | +700% |
| FY2019 | 253 | +86% |
| FY2018 | 136 | +0% |
| FY2017 | 136 | +1% |
| FY2016 | 135 | +22% |
| FY2015 | 110 | +27% |
| FY2014 | 87 | +400% |
| FY2013 | 17 | −54% |
| FY2013 | 38 | +119% |
| FY2012 | 17 | +0% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.8M | +222% | |
| Q1 FY26 | 1.8M | +238% | |
| Q4 FY25 | 1.8M | +335% | |
| Q3 FY25 | 1.8M | +514% | |
| Q2 FY25 | 557.8K | +186% | |
| Q1 FY25 | 530.6K | +382% | |
| Q4 FY24 | 412.3K | +441% | |
| Q3 FY24 | 292.3K | +348% | |
| Q2 FY24 | 194.8K | +245% | |
| Q1 FY24 | 110.2K | +883% | |
| Q4 FY23 | 76.1K | +651% | |
| Q3 FY23 | 65.3K | +809% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Bone Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.